Despite the significant burden imposed by VTE and the availability of effective anticoagulant therapies, many cancer patients do not receive appropriate, guidelines-recommended VTE prophylaxis. Annals of Oncology
Carcinoma in situ (CIS) of the bladder can appear as normal tissue on cystoscopy. However, specific histologic and immunochemical characteristics are critical to diagnosis. The current review examines the diagnosis and management of CIS of the bladder. Journal of the National Comprehensive Cancer Network
In this expert interview, Dr. Gary Hudes addresses prognostication and individualization of targeted and other therapies for patients with renal cell carcinoma as well as management of known and emerging toxicities. Medscape Hematology-Oncology
This article takes a look at caspase 2 and its potential roles in DNA damage response, cell cycle regulation, and tumor suppression. Nature Reviews Cancer